ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,277Medicare Part D Prescriptions Filled, Including Refills

Rank: 71 out of 1000

$733K Total Retail Price of All Prescriptions

Rank: 129 out of 1000

533 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 533 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

16% of this provider’s 533 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

1% of this provider’s 14,077 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
AMLODIPINE BESYLATE 1,141 970 1 6
SIMVASTATIN 958 702 2 3
CITALOPRAM HBR 831 653 3 17
LISINOPRIL 605 444 4 5
LEVOTHYROXINE SODIUM 527 463 5 4
TRAZODONE HCL 505 355 6 29
FUROSEMIDE 456 324 7 7
OMEPRAZOLE 456 321 7 2
PRAVASTATIN SODIUM 413 323 9 12
METOPROLOL TARTRATE 363 233 10 19
HYDROCODONE-ACETAMINOPHEN 352 283 S3 11 1
LISINOPRIL-HYDROCHLOROTHIAZIDE 339 236 12 20
HYDROCHLOROTHIAZIDE 297 181 13 9
WARFARIN SODIUM 297 210 13 22
DONEPEZIL HCL 247 242 15 32
CARVEDILOL 237 175 16 15
POTASSIUM CHLORIDE 232 192 17 10
ATENOLOL 232 194 17 24
TRAMADOL HCL 226 129 19 13
METFORMIN HCL ER 218 139 20 44
METFORMIN HCL 217 186 21 8
METOPROLOL SUCCINATE 211 164 22 21
GABAPENTIN 208 119 23 11
RANITIDINE HCL 205 87 24 37
FELODIPINE ER 199 124 25 210
MELOXICAM 164 143 26 14
NAMENDA 156 147 27 43
RISPERIDONE 151 138 28 87
MIRTAZAPINE 151 124 28 56
ATORVASTATIN CALCIUM 142 107 30 18
TAMSULOSIN HCL 140 116 31 33
NAPROXEN 138 95 32 81
QUETIAPINE FUMARATE 133 106 33 75
GLIMEPIRIDE 133 121 33 34
TRIAMTERENE-HCTZ 128 120 35 48
IBUPROFEN 125 58 36 94
SERTRALINE HCL 122 116 37 26
CLOPIDOGREL 120 86 38 35
AZITHROMYCIN 119 88 39 36
CLONIDINE HCL 115 102 40 27
ISOSORBIDE MONONITRATE ER 112 96 41 71
FOSINOPRIL SODIUM 104 62 42 154
FLUCONAZOLE 103 76 43 102
FLUOXETINE HCL 97 30 44 51
HYDRALAZINE HCL 90 79 45 74
ALENDRONATE SODIUM 86 86 46 57
DOXAZOSIN MESYLATE 83 53 47 111
NEXIUM 82 50 48 23
LANTUS 78 46 49 68
PLAVIX 78 60 49 49
INDAPAMIDE 76 76 51 164
PAROXETINE HCL 76 64 51 63
SEROQUEL 74 63 53 157
PANTOPRAZOLE SODIUM 73 55 54 28
METRONIDAZOLE 72 53 55 281
ALLOPURINOL 71 63 56 31
BENAZEPRIL HCL 71 52 56 61
BUSPIRONE HCL 69 44 58 110
GLIPIZIDE 67 48 59 62
EXELON 67 67 59 108
TERAZOSIN HCL 65 39 61 150
FLUTICASONE PROPIONATE 64 28 62 40
ATENOLOL-CHLORTHALIDONE 64 59 62 206
PROMETHAZINE HCL 63 14 R 64 54
BACLOFEN 63 26 64 129
LEVETIRACETAM 62 13 66 128
GLYBURIDE 61 38 R 67 92
BUPROPION HCL SR 61 0 67 183
DIGOXIN 61 48 67 52
PHENYTOIN SODIUM EXTENDED 61 41 67 115
INSULIN SYRINGE 60 26 71 93
NUEDEXTA 60 25 71 290
BETHANECHOL CHLORIDE 59 46 73 416
DIOVAN 58 58 74 67
CYCLOBENZAPRINE HCL 57 27 R 75 39
NIASPAN 55 44 76 172
ENALAPRIL MALEATE 51 39 77 58
LOSARTAN POTASSIUM 51 34 77 25
ZOLPIDEM TARTRATE 51 37 77 16
BENZTROPINE MESYLATE 51 50 R 77 180
HUMULIN R 50 33 81 215
LEVEMIR 50 50 81 179
ROPINIROLE HCL 50 23 81 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 9, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.